Yasuo Morishima


Ontology type: schema:Person     


Person Info

NAME

Yasuo

SURNAME

Morishima

Publications in SciGraph latest 50 shown

  • 2018-01 HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation in LEUKEMIA
  • 2017-12 Associations of interactions between NLRP3 SNPs and HLA mismatch with acute and extensive chronic graft-versus-host diseases in SCIENTIFIC REPORTS
  • 2017-06 Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-03 Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation in LEUKEMIA
  • 2016-03 A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2016-03 Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes in BONE MARROW TRANSPLANTATION
  • 2016-01 Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2015-12 Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next generation sequencing in BMC GENOMICS
  • 2015-10 Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2015-10 A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2015-04 Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT in BONE MARROW TRANSPLANTATION
  • 2014-12 Decision analysis for donor selection in stem cell transplantation—HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor in BLOOD CANCER JOURNAL
  • 2014-12 Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT in BONE MARROW TRANSPLANTATION
  • 2014-09 Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell Transplantation retrospective analysis in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2014-03 Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT in BONE MARROW TRANSPLANTATION
  • 2014-02 PBSC collection from family donors in Japan: a prospective survey in BONE MARROW TRANSPLANTATION
  • 2014-02 Risk factors and organ involvement of chronic GVHD in Japan in BONE MARROW TRANSPLANTATION
  • 2014-01 Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis in BONE MARROW TRANSPLANTATION
  • 2013-11 Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation in BONE MARROW TRANSPLANTATION
  • 2013-11 Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission in BLOOD CANCER JOURNAL
  • 2013-11 Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation in BONE MARROW TRANSPLANTATION
  • 2013-11 Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) in BONE MARROW TRANSPLANTATION
  • 2013-10 Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2013-10 Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2013-09 Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia in BONE MARROW TRANSPLANTATION
  • 2013-08 The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis in BONE MARROW TRANSPLANTATION
  • 2013-08 Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas in LEUKEMIA
  • 2013-06 Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation in IMMUNOGENETICS
  • 2013-04 Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry in BONE MARROW TRANSPLANTATION
  • 2013-01 Erratum to: Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-01 Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR in BONE MARROW TRANSPLANTATION
  • 2012-12 Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-01 Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas in LEUKEMIA
  • 2011-11 Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2011-11 A single nucleotide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMT in BONE MARROW TRANSPLANTATION
  • 2011-09 Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan marrow donor program in BONE MARROW TRANSPLANTATION
  • 2011-06 Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility in JOURNAL OF HUMAN GENETICS
  • 2011-06 Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2011-04 High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2011-03 Nodal Relapse After Helicobacter pylori Eradication in a Patient With Primary Localized Gastric Mucosa-Associated Lymphoid Tissue Lymphoma in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2011-02 A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies in BONE MARROW TRANSPLANTATION
  • 2011-01 Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia in LEUKEMIA
  • 2010-04 Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2010-04 Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2009-05 Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2009-04 Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study in BONE MARROW TRANSPLANTATION
  • 2009-04 Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2009-01 Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2008-06 Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: application for allogeneic transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2007-12 Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma in LEUKEMIA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.410800.d", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.256115.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416762.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411234.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413724.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412757.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.265107.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.258269.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416813.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.260026.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.260969.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.26999.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414342.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410793.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.263518.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.497282.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.272458.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.63906.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414470.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412342.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.256342.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.27476.30", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.265061.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.39158.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.261356.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414932.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414157.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412767.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415258.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.440090.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.263171.0", 
            "type": "Organization"
          }
        ], 
        "familyName": "Morishima", 
        "givenName": "Yasuo", 
        "id": "sg:person.01202560642.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202560642.44"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:41", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_448.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01202560642.44'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01202560642.44'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01202560642.44'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01202560642.44'


     

    This table displays all metadata directly associated to this object as RDF triples.

    78 TRIPLES      10 PREDICATES      42 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01202560642.44 schema:affiliation N37b6acb599ba4775a56b08c833468321
    2 https://www.grid.ac/institutes/grid.256115.4
    3 https://www.grid.ac/institutes/grid.256342.4
    4 https://www.grid.ac/institutes/grid.258269.2
    5 https://www.grid.ac/institutes/grid.260026.0
    6 https://www.grid.ac/institutes/grid.260969.2
    7 https://www.grid.ac/institutes/grid.261356.5
    8 https://www.grid.ac/institutes/grid.263171.0
    9 https://www.grid.ac/institutes/grid.263518.b
    10 https://www.grid.ac/institutes/grid.265061.6
    11 https://www.grid.ac/institutes/grid.265107.7
    12 https://www.grid.ac/institutes/grid.26999.3d
    13 https://www.grid.ac/institutes/grid.272458.e
    14 https://www.grid.ac/institutes/grid.27476.30
    15 https://www.grid.ac/institutes/grid.39158.36
    16 https://www.grid.ac/institutes/grid.410793.8
    17 https://www.grid.ac/institutes/grid.411234.1
    18 https://www.grid.ac/institutes/grid.412342.2
    19 https://www.grid.ac/institutes/grid.412757.2
    20 https://www.grid.ac/institutes/grid.412767.1
    21 https://www.grid.ac/institutes/grid.413724.7
    22 https://www.grid.ac/institutes/grid.414157.2
    23 https://www.grid.ac/institutes/grid.414342.4
    24 https://www.grid.ac/institutes/grid.414470.2
    25 https://www.grid.ac/institutes/grid.414932.9
    26 https://www.grid.ac/institutes/grid.415258.f
    27 https://www.grid.ac/institutes/grid.416762.0
    28 https://www.grid.ac/institutes/grid.416813.9
    29 https://www.grid.ac/institutes/grid.440090.9
    30 https://www.grid.ac/institutes/grid.497282.2
    31 https://www.grid.ac/institutes/grid.51462.34
    32 https://www.grid.ac/institutes/grid.63906.3a
    33 schema:familyName Morishima
    34 schema:givenName Yasuo
    35 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202560642.44
    36 schema:sdDatePublished 2019-03-07T14:41
    37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    38 schema:sdPublisher N763cdc5e84f74e929db83f63336997a1
    39 sgo:license sg:explorer/license/
    40 sgo:sdDataset persons
    41 rdf:type schema:Person
    42 N37b6acb599ba4775a56b08c833468321 schema:affiliation https://www.grid.ac/institutes/grid.410800.d
    43 sgo:isCurrent true
    44 rdf:type schema:OrganizationRole
    45 N763cdc5e84f74e929db83f63336997a1 schema:name Springer Nature - SN SciGraph project
    46 rdf:type schema:Organization
    47 https://www.grid.ac/institutes/grid.256115.4 schema:Organization
    48 https://www.grid.ac/institutes/grid.256342.4 schema:Organization
    49 https://www.grid.ac/institutes/grid.258269.2 schema:Organization
    50 https://www.grid.ac/institutes/grid.260026.0 schema:Organization
    51 https://www.grid.ac/institutes/grid.260969.2 schema:Organization
    52 https://www.grid.ac/institutes/grid.261356.5 schema:Organization
    53 https://www.grid.ac/institutes/grid.263171.0 schema:Organization
    54 https://www.grid.ac/institutes/grid.263518.b schema:Organization
    55 https://www.grid.ac/institutes/grid.265061.6 schema:Organization
    56 https://www.grid.ac/institutes/grid.265107.7 schema:Organization
    57 https://www.grid.ac/institutes/grid.26999.3d schema:Organization
    58 https://www.grid.ac/institutes/grid.272458.e schema:Organization
    59 https://www.grid.ac/institutes/grid.27476.30 schema:Organization
    60 https://www.grid.ac/institutes/grid.39158.36 schema:Organization
    61 https://www.grid.ac/institutes/grid.410793.8 schema:Organization
    62 https://www.grid.ac/institutes/grid.410800.d schema:Organization
    63 https://www.grid.ac/institutes/grid.411234.1 schema:Organization
    64 https://www.grid.ac/institutes/grid.412342.2 schema:Organization
    65 https://www.grid.ac/institutes/grid.412757.2 schema:Organization
    66 https://www.grid.ac/institutes/grid.412767.1 schema:Organization
    67 https://www.grid.ac/institutes/grid.413724.7 schema:Organization
    68 https://www.grid.ac/institutes/grid.414157.2 schema:Organization
    69 https://www.grid.ac/institutes/grid.414342.4 schema:Organization
    70 https://www.grid.ac/institutes/grid.414470.2 schema:Organization
    71 https://www.grid.ac/institutes/grid.414932.9 schema:Organization
    72 https://www.grid.ac/institutes/grid.415258.f schema:Organization
    73 https://www.grid.ac/institutes/grid.416762.0 schema:Organization
    74 https://www.grid.ac/institutes/grid.416813.9 schema:Organization
    75 https://www.grid.ac/institutes/grid.440090.9 schema:Organization
    76 https://www.grid.ac/institutes/grid.497282.2 schema:Organization
    77 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    78 https://www.grid.ac/institutes/grid.63906.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...